About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–

Showing 7 of 168

Regulatory and ClinicalAug 11, 2025 · 5:31am ET

IOBTQIO Biotech, Inc.

IO Biotech Announced Topline Results from Phase 3 Trial of Cylembio Plus KEYTRUDA

Clinical improvement in progression free survival observed but statistical significance narrowly missed.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+62.9%

RVOL

5.5x

Max high

$3.29

Fuel

2h 12m

Regulatory and ClinicalAug 11, 2025 · 5:31am ET

IOBTQIO Biotech, Inc.+62.9%

IO Biotech Announced Topline Results from Phase 3 Trial of Cylembio Plus KEYTRUDA

RVOL

5.5x

Max high

$3.29

Fuel

2h 12m

Regulatory and ClinicalAug 6, 2025 · 7:59pm ET

PALIPALISADE BIO, INC.

Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with PALI-2108

Company announces positive results for novel PDE4 inhibitor

Regulatory and ClinicalAug 6, 2025 · 7:59pm ET

PALIPALISADE BIO, INC.+88.1%

Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with PALI-2108

Regulatory and ClinicalAug 4, 2025 · 9:46am ET

CASIFCASI PHARMACEUTICALS INC

CASI Pharmaceuticals Receives FDA Clearance for IND Application for CID-103

The clearance allows CASI to proceed with clinical trials.

Regulatory and ClinicalAug 4, 2025 · 9:46am ET

CASIFCASI PHARMACEUTICALS INC+89.0%

CASI Pharmaceuticals Receives FDA Clearance for IND Application for CID-103

Regulatory and ClinicalJul 28, 2025 · 7:35am ET

CRVOCervoMed Inc. Common Stock

CervoMed Announces Sustained Effect of Neflamapimod in Dementia with Lewy Bodies Trial

CervoMed Inc. disclosed 32-week data from the RewinD-LB trial extension phase.

Regulatory and ClinicalJul 28, 2025 · 7:35am ET

CRVOCervoMed Inc. Common Stock+85.1%

CervoMed Announces Sustained Effect of Neflamapimod in Dementia with Lewy Bodies Trial

Regulatory and ClinicalJul 28, 2025 · 6:39am ET

CELCCelcuity Inc. Common Stock

Celcuity Inc. Announces Positive Topline Results from VIKTORIA-1 Trial

Results show improved progression-free survival in breast cancer patients.

Regulatory and ClinicalJul 28, 2025 · 6:39am ET

CELCCelcuity Inc. Common Stock+297.3%

Celcuity Inc. Announces Positive Topline Results from VIKTORIA-1 Trial

Regulatory and ClinicalJul 21, 2025 · 7:59pm ET

PLRZPolyrizon Ltd.

Polyrizon Ltd. Reports Successful Preclinical Results for PL-14 Allergy Blocker

Demonstrated over 60% targeted nasal deposition in the nasal vestibule.

Regulatory and ClinicalJul 21, 2025 · 7:59pm ET

PLRZPolyrizon Ltd.+107.8%

Polyrizon Ltd. Reports Successful Preclinical Results for PL-14 Allergy Blocker

Regulatory and ClinicalJul 21, 2025 · 9:00am ET

RDHLRedHill Biopharma Ltd.

RedHill Biopharma Receives FDA Guidance on RHB-204 Crohn's Disease Program

Company held a Type C meeting with the FDA.

Regulatory and ClinicalJul 21, 2025 · 9:00am ET

RDHLRedHill Biopharma Ltd.+70.6%

RedHill Biopharma Receives FDA Guidance on RHB-204 Crohn's Disease Program

1
…
16
17
18
…
24

RVOL

3.9x

Max high

$1.90

Fuel

24m

RVOL

1.8x

Max high

$2.57

Fuel

35m

RVOL

7.3x

Max high

$16.70

Fuel

44m

RVOL

10.3x

Max high

$59.60

Fuel

17m

RVOL

1.1x

Max high

$11.22

Fuel

2h 26m

RVOL

15.6x

Max high

$3.31

Fuel

4h 17m